The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Abstract
PURPOSE: This is the first published report on the validation of the Functional Assessment of Cancer Therapy-Breast (FACT-B), a 44-item self-report instrument designed to measure multidimensional quality of life (QL) in patients with breast cancer. The FACT-B consists of the FACT-General (FACT-G) plus the Breast Cancer Subscale (BCS), which complements the general scale with items specific to QL in breast cancer. The FACT-B was developed with an emphasis on patients' values and brevity and is available in nine languages. METHODS AND RESULTS: Two validation samples were used for this report. The first (n = 47) was tested twice over a 2-month period to assess sensitivity to change. Significant sensitivity to change in performance status rating (PSR) was demonstrated for the FACT-B total score, the Physical Well-Being (PWB) subscale, the Functional Well-Being (FWB) subscale, and the BCS. Sensitivity to change in QL as measured by the Functional Living Index-Cancer (FLIC) was documented in the FACT-B total score, PWB, FWB, and Emotional Well-Being (EWB). Additional validity and reliability data were obtained from a larger sample (n = 295). The alpha coefficient (internal consistency) for the FACT-B total score was high (alpha = .90), with subscale alpha coefficients ranging from .63 to .86. Evidence supported test-retest reliability, as well as convergent, divergent, and known groups validity. CONCLUSION: The FACT-B is appropriate for use in oncology clinical trials, as well as in clinical practice. It demonstrates ease of administration, brevity, reliability, validity, and sensitivity to change.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed mean improvements presented within this evaluation exceeded this for both groups.”
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citationShort, homogeneous versions of the Marlow-Crowne Social Desirability Scale
Strahan, R. F., & Gerbasi, K. C. (1972) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197204)28:2 · Cited by 1,657
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,057
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Zubrod, C. G., Schneiderman, M. A., Frei, E., Brindley, C. O., Gold, G. L., Shnider, B. I., Oviedo, R., Gorman, J. G., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 903
Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E. J., & Bonomi, P. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00450-f · Cited by 750
Self-citationImproving the Quality of Life during Chemotherapy for Advanced Breast Cancer
Coates, A. S., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Snyder, R., Tattersall, M. H. N., Byrne, M., Harvey, V. J., Gill, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172402 · Cited by 534
Principles of Psychological Measurement
Dale, R. R., & Helmstadter, G. C. (1968) · British Journal of Educational Studies · doi:10.2307/3119229 · Cited by 487
Osoba, D., Zee, B. C.-Y., Pater, J. L., Warr, D. G., Kaizer, L., & Latreille, J. (1994) · Quality of Life Research · doi:10.1007/bf00451727 · Cited by 412
EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER
Priestman, T. J., & Baum, M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92112-7 · Cited by 399
Bonomi, A. E., Cella, D. F., Hahn, E. A., Bjordal, K., Sperner‐Unterweger, B., Gangeri, L., Bergman, B., Willems-Groot, J., Hanquet, P., & Zittoun, R. (1996) · Quality of Life Research · doi:10.1007/bf00433915 · Cited by 399
Self-citationLoprinzi, C. L., Laurie, J. A., Wieand, H. S., Krook, J. E., Novotny, P. J., Kugler, J. W., Bartel, J., Law, M., Bateman, M., & Klatt, N. E. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.601 · Cited by 387
Psychosocial correlates of breast cancer and its treatments.
Meyerowitz, B. E. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.1.108 · Cited by 324
Psychosocial Impact of Breast Cancer: A Critical Review
Glanz, K., & Lerman, C. (1992) · Annals of Behavioral Medicine · doi:10.1093/abm/14.3.204 · Cited by 292
The CARES: a generic measure of health-related quality of life for patients with cancer
Ganz, P. A., Schag, C. A. C., Lee, J. J., & Sim, M. (1992) · Quality of Life Research · doi:10.1007/bf00435432 · Cited by 244
Food and Drug Administration requirements for approval of new anticancer drugs.
Johnson, J. R., & Temple, R. (1985) · PubMed · Cited by 234
Quality of life in stage II breast cancer: an instrument for clinical trials.
Levine, M. N., Guyatt, G. H., Gent, M., Pauw, S. D., Goodyear, M. D. E., Hryniuk, W. M., Arnold, A., Findlay, B., Skillings, J. R., & Bramwell, V. H. C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1798 · Cited by 222
A brief poms measure of distress for cancer patients
Cella, D. F., Jacobsen, P. B., Orav, E. J., Holland, J. C., Silberfarb, P. M., & Rafla, S. D. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90143-3 · Cited by 197
Self-citationChanging trends: An overview of breast cancer incidence and mortality
Garfinkel, L., Boring, C. C., & Heath, C. W. (1994) · Cancer · doi:10.1002/cncr.2820741304 · Cited by 158
Minnesota multiphasic personality inventory-rated depression and the incidence of breast cancer
Hahn, R. C., & Petitti, D. B. (1988) · Cancer · doi:10.1002/1097-0142(19880215)61:4 · Cited by 157
Someone to live for: social well-being, parenthood status, and decision-making in oncology.
Yellen, S. B., & Cella, D. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1255 · Cited by 145
Self-citationNayfield, S., Ganz, P. A., Moinpour, C. M., Cella, D. F., & Hailey, B. J. (1992) · Quality of Life Research · doi:10.1007/bf00635619 · Cited by 135
Self-citationAssessing the quality of life—a study in newly-diagnosed breast cancer patients
Ganz, P., Schagi, C. A. C., & Cheng, H.-L. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90059-x · Cited by 117
Sneeuw, K. C. A., Aaronson, N. K., Yarnold, J. R., Broderick, M., Regan, J., Ross, G., & Goddard, A. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90262-s · Cited by 112
Mastectomy versus breast conservation surgery: Mental health effects at long-term follow-up.
Levy, S. M., Haynes, L. T., Herberman, R. B., Lee, J. W., McFeeley, S., & Kirkwood, J. (1992) · Health Psychology · doi:10.1037//0278-6133.11.6.349 · Cited by 88
Bergman, B., Sullivan, M., & Sörenson, S. (1992) · Acta Oncologica · doi:10.3109/02841869209088260 · Cited by 86
A reversal in the long-term increase in deaths attributable to malignant melanoma
Roush, G. C., McKay, L. A., & Holford, T. R. (1992) · Cancer · doi:10.1002/1097-0142(19920401)69:7 · Cited by 71
The Influence of Stress Management Training In HIV Disease
McCain, N. L., Zeller, J. M., Cella, D. F., Urbanski, P. A., & Novak, R. M. (1996) · Nursing Research · doi:10.1097/00006199-199607000-00009 · Cited by 68
Self-citationFacilitating emotional coping during treatment
Spiegel, D. (1990) · Cancer · doi:10.1002/1097-0142(19900915)66:14+ · Cited by 67
Quality of Life Assessment in Cancer Clinical Trials
Aaronson, N. K. (1990) · Springer eBooks · doi:10.1007/978-3-642-46695-3_11 · Cited by 58
Kantarjian, H. M., Talpaz, M., Keating, M. J., Estey, E. H., O'Brien, S. M., Beran, M., McCREDIE, K. B., Gutterman, J. U., & Freireich, E. J. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6 · Cited by 51
Breast Cancer Death Rates Decline for White Women
Smigel, K. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.173 · Cited by 33
Eisbruch, A., Blick, M. B., Evinger-Hodges, M. J., Beran, M., Andersson, B. A. R., Gutterman, J. U., & Kurzrock, R. (1988) · Cancer · doi:10.1002/1097-0142(19880915)62:6 · Cited by 30
Quality of Life in Breast Cancer-Results from 3 Cancer Research Campaign Studies
Fallowfield, L. J. (1993) · Acta Clinica Belgica · doi:10.1080/17843286.1993.11718348 · Cited by 5
Flagged first, then by citations
Cited by
Sorted by citations
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K. D., Wang, M., Gralow, J. R., Dickler, M. N., Cobleigh, M., Perez, E. A., Shenkier, T. N., Cella, D. F., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,104
Self-citationAmerican College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., GALVÃO, D. A., Pinto, B. M., IRWIN, M. L., WOLIN, K. Y., SEGAL, R. J., LUCIA, A., et al. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0c112 · Cited by 2,781
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964
Self-citationMansel, R. E., Fallowfield, L. J., Kissin, M. W., Goyal, A., Newcombe, R. G., Dixon, J. M., Yiangou, C., Horgan, K. J., Bundred, N. J., Monypenny, I. J., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj158 · Cited by 1,679
Metadata
- Authors
- Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G.
- Affiliations
- Rush University Medical Center (US)
- Rush University (US)
- Venue
- Journal of Clinical Oncology
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 974-986
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1857624176
- Cited by
- 1,752
- References
- 39
- Citations by year
- 2026: 47 · 2025: 76 · 2024: 77 · 2023: 71 · 2022: 97 · 2021: 88 · 2020: 78 · 2019: 87 · 2018: 83 · 2017: 85 · 2016: 83 · 2015: 73 · 2014: 83 · 2013: 70 · 2012: 86
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ca051926-01a1)
- National Cancer Institute (R29CA51926)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- FACT-B, breast cancer, quality of life, FACT-G, instrument validation, sensitivity to change, test-retest reliability, internal consistency, known-groups validity, convergent validity, discriminant validity, physical well-being, functional well-being, emotional well-being, Functional Living Index-Cancer, self-report questionnaire
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Quality of Life, Self Concept, Sensitivity and Specificity, Severity of Illness Index, Translations, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review